These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21732822)

  • 1. Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs).
    Huzair F; Borda-Rodriguez A; Upton M
    OMICS; 2011 Sep; 15(9):539-43. PubMed ID: 21732822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
    Ozdemir V; Faraj SA; Knoppers BM
    OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe.
    Joly Y; Koutrikas G; Ramos-Paque E; Zawati M; Gardy J; Hayden MR; Carleton BC
    OMICS; 2011 Sep; 15(9):597-605. PubMed ID: 21728814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation.
    Ozdemir V; Pang T; Knoppers BM; Avard D; Faraj SA; Zawati MH; Kolker E
    OMICS; 2011 Sep; 15(9):523-7. PubMed ID: 21848418
    [No Abstract]   [Full Text] [Related]  

  • 5. The strategic approach to contraceptive introduction.
    Simmons R; Hall P; Díaz J; Díaz M; Fajans P; Satia J
    Stud Fam Plann; 1997 Jun; 28(2):79-94. PubMed ID: 9216029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Publics and vaccinomics: beyond public understanding of science.
    Einsiedel EF
    OMICS; 2011 Sep; 15(9):607-14. PubMed ID: 21732820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latin American countries set 1985 EPI targets at Lima meeting.
    EPI Newsl; 1984 Apr; 6(2):1-3. PubMed ID: 12313077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why might regional vaccinology networks fail? The case of the Dutch-Nordic Consortium.
    Hendriks J; Blume S
    Global Health; 2016 Jul; 12(1):38. PubMed ID: 27388678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making primary health care work: the case of Fundacao Esperanca.
    Offenheiser RC
    Grassroots Dev; 1986; 10(2):22-9. PubMed ID: 12269085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling product development partnerships to bring forward the next generation of health technologies.
    So AD; Woo J; Helble M
    Health Aff Sch; 2024 Jan; 2(1):qxad088. PubMed ID: 38770112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems vaccinomics: the road ahead for vaccinology.
    Bernstein A; Pulendran B; Rappuoli R
    OMICS; 2011 Sep; 15(9):529-31. PubMed ID: 21827321
    [No Abstract]   [Full Text] [Related]  

  • 13. Technological and social innovation: a unifying new paradigm for global health.
    Gardner CA; Acharya T; Yach D
    Health Aff (Millwood); 2007; 26(4):1052-61. PubMed ID: 17630448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher coverage attained through public participation: National Vaccination Days in Bolivia.
    EPI Newsl; 1985 Feb; 7(1):4-6. PubMed ID: 12268041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universities as catalysts of social innovation in health systems in low-and middle-income countries: a multi-country case study.
    van Niekerk L; Mathanga DP; Juban N; Castro-Arroyave DM; Balabanova D
    Infect Dis Poverty; 2020 Jul; 9(1):90. PubMed ID: 32650822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".
    Dove ES; Barlas IÖ; Birch K; Boehme C; Borda-Rodriguez A; Byne WM; Chaverneff F; Coşkun Y; Dahl ML; Dereli T; Diwakar S; Elbeyli L; Endrenyi L; Eroğlu-Kesim B; Ferguson LR; Güngör K; Gürsoy U; Hekim N; Huzair F; Kaushik K; Kickbusch I; Kıroğlu O; Kolker E; Könönen E; Lin B; Llerena A; Malhan F; Nair B; Patrinos GP; Şardaş S; Sert Ö; Srivastava S; Steuten LM; Toraman C; Vayena E; Wang W; Warnich L; Özdemir V
    OMICS; 2015 Aug; 19(8):435-42. PubMed ID: 26161545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.